A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be ...
Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
A participant in a landmark clinical trial has been given a cellular-reprogramming treatment that aims to rejuvenate damaged ...
Proprietary Synthetic Polynucleotide Platform Accelerates Non-Viral, Footprint-Free Induced Pluripotent Stem Cell Generation Amid Surging Commercialization of iPSC Therapies in Japan ...
Personalized disease treatment, tailored to an individual’s genetic background, is the future of medicine. Stem cells hold the promise of that objective becoming a reality. A decade ago, the discovery ...
World’s first anti-ageing gene therapy trial begins as ER-100 is injected into a human eye, testing partial cellular ...
The approach relies on “reprogramming” cells to a younger state. It’s one of many strategies being explored by biotech ...